Top
RALGPS2 has not been detected as a mutational cancer driver

RALGPS2
Ensembl id ENSG00000116191
Mutated samples
Coding Sequence 75 (1.1%)
Protein Affecting 30 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all RALGPS2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 20 10 2.71
Lung adenocarcinoma No 7 4 1.02
Lung squamous cell carcinoma No 4 3 1.72
Renal clear cell carcinoma No 2 2 0.48
Uterine corpus endometrioid carcinoma No 4 2 0.87
Small cell lung carcinoma No 2 2 2.90
Hepatocarcinoma No 4 1 1.11
Bladder carcinoma No 1 1 1.02
Thyroid carcinoma No 3 1 0.31
Multiple myeloma No 1 1 1.45
Stomach adenocarcinoma No 1 1 0.62
Head and neck squamous cell carcinoma No 3 1 0.27
Esophageal carcinoma No 1 1 0.68
Prostate adenocarcinoma No 1 0 0.00
Breast carcinoma No 6 0 0.00
Pancreas adenocarcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 8 0 0.00
Lower grade glioma No 1 0 0.00
Pylocytic astrocytoma No 2 0 0.00
Diffuse B cell lymphoma No 1 0 0.00
Glioblastoma multiforme No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence